EFIB 2011 
18-19 October 2011
Novotel Amsterdam City
Amsterdam
A packed plenary session of 350 attendees closed EFIB 2011 with a call to arms for the biobased economy.
The closing keynote from Roger Wyse of Burrill Partners demonstrated both huge opportunities in this sector and the tough challenges that lie ahead. A significant number of partnerships and collaborations between start ups and large multinationals are now delivering innovative new products to address retail and consumer pull for biobased products. However, sources of both funding and feedstock are still needed to enable biobased economy to deliver on its promise.
Over 70 speakers from across the value chain including financers and venture capitalists, policy makers and government officials, start ups and senior industry figures gave presentations and engaged in debate to look at these opportunities and challenges in depth. Their insight and knowledge sharing enabled attendees to leave the conference equipped with the knowledge to succeed.
Attendees also took full advantage of the comprehensive networking sessions and the partnering tools provided to host over 500 private meetings at the conference and develop essential contacts and networks to help build this dynamic, fast growing market place.
This unrivalled blend of content and contacts made EFIB 2011 the must attend conference for the biobased economy.
"EFIB brings a variety of insights (technical, political and global) from high level speakers"
"EFIB is an always growing event with excellent partnering opportunities"
"EFIB is the place to meet the top of the industrial biotechnology sector"
"Interesting people with interesting content to share"
Click here to see a break down of who attended in 2011 >>
EFIB 2010
19-21 October 2010
Sheraton Grand Hotel & Spa Edinburgh
Scotland, UK
Interviews from EFIB 2010
EuropaBio's Dirk Carrez on the 2010 European Forum for Industrial Biotechnology
EuropaBio's Nathalie Moll on the bio-based economy: EFIB 2010 Edinburgh
BioIsoprene Tyre: Genencor's Karl Sanford explains collaboration with Goodyear
DSM's Stephan Tanda on the need for bio-economy: EFIB 2010 Edinburgh
Bruce Dale interview at EFIB 2010 Edinburgh
EFIB 2010 in numbers:
- 325 attendees from 28 countries spanning Europe, Asia, Australia, America and Middle East
- over 60 speakers presented at the main conference, plus further 9 spoke at pre-conference workshops
- the event was supported by 25 sponsors and exhibitors, including companies such as Genencor, TNO, DSM, DuPont, SüdChemie, Purac, Biocatalysts, Avantium, c-Lecta
See EFIB 2010 photos at 
-----------------------------------------------------------------------------------------------------------------------
EFIB 2009
20 - 22 October 2009
SANA Lisboa, Lisbon, Portugal
Interviews from EFIB 2009
Interview with Lars Hansen
Interview with Stuart West
Interview with John Kornerup Bang
EFIB 2009 brought together over 250 policy makers, representatives from NGOs, industry associations and initiatives, industrial biotechnology companies, materials and equipment suppliers, end users, consultants, researchers, investors, academia and media from 28 countries to discuss the crucial issues the IB sector is facing nowadays.
EFIB 2009 featured:
- 2 parallel pre-conference seminars
- 2 plenary sessions featuring presentations from the European Commission, Evonik Degussa, Huntsman Textile Effects, Novozymes, Toyota Motor, WWF and many others
- Parallel tracks dedicated to Feedstock, Policy, Innovative Biobased Products and Innovation
- 7 panel debates
- 22 exhibitors
- 4 brokerage events and the site visit to Biocant Park and the University of Coimbra
See EFIB 2009 photos at
-----------------------------------------------------------------------------------------------------------------------
EFIB 2008
15 - 17 September 2008
Hotel Bloom!, Brussels, Belgium
Over 260 delegates from 23 countries from industry, research, policy making and investment fields attended the inaugural European Forum of Industrial Biotechnology, held in Brussels from 15 -17 September 2008. Organised jointly by EuropaBio and IntertechPira, the event featured 50 leading speakers who assessed the prospects for industrial biotechnology in Europe.